REFERENCES
- Keith C T, Borisy A A, Stockwell B R. Multicomponent therapeutics for networked systems. Nat Rev Drug Discov 2005; 4: 1–7
- Keith C T, Zimmerman G R. Multi-target lead discovery for networked systems. Current Drug Discovery September. 2004; 19–23
- Bliss C I. The toxicity of poisons combined jointly. Ann Appl Biol 1939; 26: 585–615
- Loewe S. The problem of Synergism and Antagonism of Combined Drugs. Arzeim Forsch 1953; 3: 285–290
- Greco, Bravo, Parsons. The Search for Synergy: A Critical Review from a Response Surface Perspective. Pharmacol Rev 1995; 47: 331–385
- Lehar J, Keith C. “Quantifying the effects of compound combinations”. International Union of Pure and Applied Chemistry (IUPAC) Project Description. 2004, http://sunsite.wits.ac.za/iupac/projects/2003/2003-059-1-700.html(Project Number: 2003-059-1-700) available at
- Chou T C, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Reg 1984; 22: 27–55
- Steel G G, Peckham M J. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Rad Oncol Biol Physics 1979; 5: 85–91
- Berenbaum M C. The expected effect of a combination of agents: The general solution. J Theor Biol, 1985; 114: 413–431
- Berenbaum M C. What Is Synergy?. Pharmacol Rev, 1989; 41: 93–141
- Pritchard M N, Shipman C, Jr. Letter to the Editor. Antivir Res 1992; 17: 95–98
- Rideout D C, Chou T. Synergism, antagonism, and potentiation in chemotherapy: An overview. Synergism and Antagonism in Chemotherapy, Chou, Rideout. Academic Press, San Diego 1991
- Jones G, Wortberg M, Kreissig S B, Bunch D S, Gee S J, Hammock B D, Rocke D M. Extension of the four-parameter logistic model for ELISA to multianalyte analysis. J Immunol Methods 1994; 177: 1–7
- Jonker D M, Visser S AG, van der Graaf P H, Voskuyl R A, Danhof M. Towards a mechanism-based analysis of pharmacodynamic drug–drug interactions in vivo. Pharmacol Ther 2005; 106: 1–18
- Tallarida R J. “An Overview of Drug Combination Analysis with Isobolograms,”. J Pharmacol Exp Ther 2006, (forthcoming)
- Cornell J A. Experiments with Mixtures: Designs, Models, and the Analysis of Mixture Data, 3rd ed. John Wiley, New York 2002
- Smith W F. Experimental Design For Formulation, ASA-SIAM Series on Statistics and Applied Probability. SIAM Philadelphia, ASA, Alexandria, VA 2005
- Piepel G F, Cornell J A. Models for mixture experiments when the response depends upon the total amount. Technometrics 1985; 27: 219–227
- Piepel G F, Cornell J A. Designs for mixture-amount experiments. J Qual Technol 1987; 19: 11–28
- Claringbold P J. Use of the simplex design in the study of the joint action of related hormones. Biometrics 1955; 11: 174–185
- Minto C F, Schnider T W, Short T G, Gregg K M, Gentilini A, Shafer S L. Response Surface Model for Anesthetic Drug Interactions. Anesthesiology 2000; 92: 1603–1616
- White D B, Slocum H K, Brun Y, Wrzosek C, Greco W R. A new nonlinear mixture response surface paradigm for the study of synergism: A three drug example. Curr Drug Metab 2003; 4: 399–409
- Laska E M, Meisner M. Testing whether an identified treatment is best. Biometrics 1989; 45: 1139–1151
- Westfall P H, Ho S, Prillaman B A. Properties of Multiple Intersection-Union Tests for Multiple Endpoints in Combination Therapy Trials. J Biopharm Stat 2001; 11: 125–138
- Luszczki J J, Andres M M, Czuczwar P, Cioczek-Czuczwar A, Ratnaraj N, Patsalos P N, Czuczwar S J. Pharmacodynamic and Pharmacokinetic Characterization of Interactions between Levetiracetam and Numerous Antiepileptic Drugs in the Mouse Maximal Electroshock Seizure Model: An Isobolographic Analysis. Epilepsia 2006; 47: 10–20